Publication Name	World Journal of Stem Cells
Manuscript ID	62548
Country	Mexico

Received	2021-01-16 00:47
Peer-Review Started	2021-01-16 00:49
To Make the First Decision
Return for Revision	2021-02-14 00:18
Revised	2021-02-27 16:24
Second Decision	2021-04-20 13:10
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-04-22 14:37
Articles in Press	2021-04-22 14:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-05-07 14:53
Publish the Manuscript Online	2021-05-26 08:55

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Research & Experimental Medicine
Manuscript Type	Minireviews
Article Title	Different kinds of stem cells in the development of SARS-CoV-2 treatments
Manuscript Source	Invited Manuscript
All Author List	Monica Maribel Mata-Miranda, Miguel Sanchez-Brito and Gustavo Jesus Vazquez-Zapien
ORCID	Author(s) ORCID Number Monica Maribel Mata-Miranda http://orcid.org/0000-0002-1811-4511 Miguel Sanchez-Brito http://orcid.org/0000-0003-4371-0486 Gustavo Jesus Vazquez-Zapien http://orcid.org/0000-0002-6657-0722
Funding Agency and Grant Number
Corresponding Author	Gustavo Jesus Vazquez-Zapien, MD, PhD, Doctor, Doctor, Professor, Embryology Laboratory, Escuela Militar de Medicina, Cerrada de Palomas S/N, Mexico 11200, Mexico. gus1202@hotmail.com
Key Words	COVID-19; SARS-CoV-2; Stem cells; Exosomes; Pluripotent stem cells; Mesenchymal stem cells; Artificial stem cells
Core Tip	The use of stem cells (SCs) to address the coronavirus disease 2019 (COVID-19) pandemic has been widely studied in various fields; for example, human embryonic SCs and human induced pluripotent SCs have been used to generate functional human cells, tissues, and organoids that are used for modeling COVID-19 and discovering drugs. Mesenchymal SCs and their exosomes have been used in clinical trials to control the severe acute respiratory syndrome coronavirus 2 immune response, showing absorption of pulmonary lesions and clinical improvement.
Publish Date	2021-05-26 08:55
Citation	Mata-Miranda MM, Sanchez-Brito M, Vazquez-Zapien GJ. Different kinds of stem cells in the development of SARS-CoV-2 treatments. World J Stem Cells 2021; 13(5): 439-451
URL	https://www.wjgnet.com/1948-0210/full/v13/i5/439.htm
DOI	https://dx.doi.org/10.4252/wjsc.v13.i5.439

Full Article (PDF)	WJSC-13-439.pdf
Full Article (Word)	WJSC-13-439.docx
Manuscript File	62548_Auto_Edited_LM.docx
Answering Reviewers	62548-Answering reviewers.pdf
Audio Core Tip	62548-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	62548-Conflict-of-interest statement.pdf
Copyright License Agreement	62548-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	62548-Language certificate.pdf
Peer-review Report	62548-Peer-review(s).pdf
Scientific Misconduct Check	62548-Bing-Wang JL-1.jpg
Scientific Misconduct Check	62548-Scientific misconduct check.pdf
Scientific Editor Work List	62548-Scientific editor work list.pdf
CrossCheck Report	62548-CrossCheck report.pdf